Drabek Matthäus, Emmerich Rolf, Djulic Nuri, Bünemann Moritz, Schlitzer Martin, Kolb Peter
Department of Pharmaceutical Chemistry, University of Marburg, Germany.
Department of Pharmacology and Clinical Pharmacy, University of Marburg, Germany.
ChemMedChem. 2025 Feb 1;20(3):e202400633. doi: 10.1002/cmdc.202400633. Epub 2024 Dec 20.
We analyzed the precise ligand:receptor interactions required for activation of the muscarinic acetylcholine receptor M, a prototypical G protein-coupled receptor and potential diabetes target. Starting from literature-known compounds and docking solutions, ligands were tailored for the modulation of this receptor's activation. Several aspects of the structure-activity relationship of agonists were investigated in atomistic detail, in order to delineate how the receptor can be activated via the orthosteric site. Such exquisitely precise knowledge is instrumental for designing potent and effiacious ligands. We put this strategy into practice and acquired or synthesized and measured a diverse set of 55 ligands ranging from small fragment-like amines coordinating D to bigger molecules extending towards helices 5 and 6 with diphenyl moieties. In the course of these investigations, we showed that the polarizability of the amine nitrogen and the rigidity and size of the moieties in the space delimited by helices 5 and 6 are the two key elements distinguishing potent and efficacious ligands from those that are not. The resulting data set will be highly useful in drug design and molecular machine learning alike.
我们分析了毒蕈碱型乙酰胆碱受体M(一种典型的G蛋白偶联受体和潜在的糖尿病靶点)激活所需的精确配体:受体相互作用。从文献中已知的化合物和对接解决方案出发,对配体进行了定制,以调节该受体的激活。在原子水平上详细研究了激动剂构效关系的几个方面,以阐明受体如何通过正构位点被激活。这种极其精确的知识有助于设计出强效且有效的配体。我们将这一策略付诸实践,获得或合成并测量了55种不同的配体,范围从小的类似片段的胺(与D配位)到带有二苯基部分且向螺旋5和6延伸的更大分子。在这些研究过程中,我们表明胺氮的极化率以及螺旋5和6所界定空间中部分的刚性和大小是区分强效和有效配体与非强效和有效配体的两个关键因素。所得数据集在药物设计和分子机器学习中都将非常有用。